

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.54454201 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.54454201 |
| 3 | NIK/NF-kappaB signaling (GO:0038061) | 5.41485584 |
| 4 | GDP-mannose metabolic process (GO:0019673) | 5.28993974 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.27268974 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.27268974 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.16117267 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.81466522 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.56632631 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.53083628 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.53083628 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.53083628 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.53083628 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 4.53083628 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.53083628 |
| 16 | bile acid biosynthetic process (GO:0006699) | 4.43861114 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.31624838 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.24243622 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.24243622 |
| 20 | tryptophan catabolic process (GO:0006569) | 4.24243622 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.18138907 |
| 22 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.13542730 |
| 23 | urea metabolic process (GO:0019627) | 4.04637080 |
| 24 | urea cycle (GO:0000050) | 4.04637080 |
| 25 | mannose metabolic process (GO:0006013) | 4.04537057 |
| 26 | response to peptidoglycan (GO:0032494) | 4.02024285 |
| 27 | amyloid precursor protein catabolic process (GO:0042987) | 4.01420642 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.97302469 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 3.97268932 |
| 30 | tryptophan metabolic process (GO:0006568) | 3.91742970 |
| 31 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.78731753 |
| 32 | glutamate metabolic process (GO:0006536) | 3.77051845 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 3.76991349 |
| 34 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.76381571 |
| 35 | glyoxylate metabolic process (GO:0046487) | 3.72654358 |
| 36 | bile acid metabolic process (GO:0008206) | 3.71925429 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 3.71687327 |
| 38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.71085047 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.69319884 |
| 40 | protein retention in ER lumen (GO:0006621) | 3.67662231 |
| 41 | cysteine metabolic process (GO:0006534) | 3.66883067 |
| 42 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.66013625 |
| 43 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.64632459 |
| 44 | regulation of protein activation cascade (GO:2000257) | 3.58118198 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.55041108 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.53766175 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 3.52348862 |
| 48 | locomotory exploration behavior (GO:0035641) | 3.50482570 |
| 49 | protein carboxylation (GO:0018214) | 3.49175906 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.49175906 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.46053136 |
| 52 | protein insertion into membrane (GO:0051205) | 3.44494408 |
| 53 | reverse cholesterol transport (GO:0043691) | 3.41535991 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40590931 |
| 55 | aromatic amino acid family metabolic process (GO:0009072) | 3.40552579 |
| 56 | vocalization behavior (GO:0071625) | 3.38644945 |
| 57 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.37434723 |
| 58 | regulation of cholesterol esterification (GO:0010872) | 3.36229796 |
| 59 | synaptic vesicle maturation (GO:0016188) | 3.32785110 |
| 60 | plasma lipoprotein particle remodeling (GO:0034369) | 3.32448923 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 3.32448923 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.32448923 |
| 63 | glutamate secretion (GO:0014047) | 3.31845004 |
| 64 | regulation of complement activation (GO:0030449) | 3.31829827 |
| 65 | serine family amino acid catabolic process (GO:0009071) | 3.30967545 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 3.28827139 |
| 67 | negative regulation of cholesterol transport (GO:0032375) | 3.27422373 |
| 68 | negative regulation of sterol transport (GO:0032372) | 3.27422373 |
| 69 | adenosine receptor signaling pathway (GO:0001973) | 3.26873738 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.25842379 |
| 71 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.25076579 |
| 72 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.23687005 |
| 73 | lysine metabolic process (GO:0006553) | 3.23621617 |
| 74 | lysine catabolic process (GO:0006554) | 3.23621617 |
| 75 | tyrosine metabolic process (GO:0006570) | 3.23348815 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.22625669 |
| 77 | coenzyme catabolic process (GO:0009109) | 3.22238392 |
| 78 | regulation of chemokine biosynthetic process (GO:0045073) | 3.21593210 |
| 79 | synaptic vesicle exocytosis (GO:0016079) | 3.21426720 |
| 80 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.20127453 |
| 81 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.16178558 |
| 82 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.13952048 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 3.13328769 |
| 84 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.13090586 |
| 85 | glycosphingolipid catabolic process (GO:0046479) | 3.12641478 |
| 86 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.11272032 |
| 87 | acylglycerol homeostasis (GO:0055090) | 3.10936051 |
| 88 | triglyceride homeostasis (GO:0070328) | 3.10936051 |
| 89 | proline biosynthetic process (GO:0006561) | 3.10085377 |
| 90 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.09984680 |
| 91 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.08436802 |
| 92 | gamma-aminobutyric acid transport (GO:0015812) | 3.08405000 |
| 93 | negative regulation of viral release from host cell (GO:1902187) | 3.07839631 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 3.06389334 |
| 95 | homocysteine metabolic process (GO:0050667) | 3.05985436 |
| 96 | sterol catabolic process (GO:0016127) | 3.03810687 |
| 97 | cholesterol catabolic process (GO:0006707) | 3.03810687 |
| 98 | ketone body metabolic process (GO:1902224) | 3.02827262 |
| 99 | phospholipid efflux (GO:0033700) | 3.02241798 |
| 100 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.00171160 |
| 101 | indole-containing compound metabolic process (GO:0042430) | 2.99990451 |
| 102 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.99518533 |
| 103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.98176997 |
| 104 | neurotransmitter secretion (GO:0007269) | 2.96879058 |
| 105 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.96571573 |
| 106 | pentose metabolic process (GO:0019321) | 2.95956860 |
| 107 | drug catabolic process (GO:0042737) | 2.95931522 |
| 108 | amino-acid betaine metabolic process (GO:0006577) | 2.95401322 |
| 109 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.93739684 |
| 110 | cholesterol efflux (GO:0033344) | 2.93364737 |
| 111 | indolalkylamine metabolic process (GO:0006586) | 2.92006462 |
| 112 | cell-cell junction maintenance (GO:0045217) | 2.91791517 |
| 113 | regulation of synapse structural plasticity (GO:0051823) | 2.86302014 |
| 114 | short-chain fatty acid metabolic process (GO:0046459) | 2.86023467 |
| 115 | dicarboxylic acid catabolic process (GO:0043649) | 2.85993462 |
| 116 | behavioral response to cocaine (GO:0048148) | 2.85652640 |
| 117 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.85186051 |
| 118 | protein localization to synapse (GO:0035418) | 2.84691472 |
| 119 | negative regulation of lipase activity (GO:0060192) | 2.83944711 |
| 120 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.83915024 |
| 121 | bile acid and bile salt transport (GO:0015721) | 2.83548640 |
| 122 | glycolipid catabolic process (GO:0019377) | 2.83197057 |
| 123 | amyloid precursor protein metabolic process (GO:0042982) | 2.81348467 |
| 124 | plasma lipoprotein particle clearance (GO:0034381) | 2.81067603 |
| 125 | imidazole-containing compound metabolic process (GO:0052803) | 2.79819305 |
| 126 | cellular response to virus (GO:0098586) | 2.79665732 |
| 127 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.79362767 |
| 128 | low-density lipoprotein particle remodeling (GO:0034374) | 2.79223917 |
| 129 | cytolysis (GO:0019835) | 2.79198381 |
| 130 | benzene-containing compound metabolic process (GO:0042537) | 2.78723718 |
| 131 | aspartate family amino acid catabolic process (GO:0009068) | 2.78441477 |
| 132 | amine catabolic process (GO:0009310) | 2.76861700 |
| 133 | cellular biogenic amine catabolic process (GO:0042402) | 2.76861700 |
| 134 | exploration behavior (GO:0035640) | 2.74909274 |
| 135 | response to host immune response (GO:0052572) | 2.74084108 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.74084108 |
| 137 | modulation by symbiont of host cellular process (GO:0044068) | 2.73919547 |
| 138 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.73708515 |
| 139 | response to muramyl dipeptide (GO:0032495) | 2.73634184 |
| 140 | regulation of bile acid biosynthetic process (GO:0070857) | 2.73218288 |
| 141 | positive regulation of lipid catabolic process (GO:0050996) | 2.72428614 |
| 142 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72313865 |
| 143 | regulation of cholesterol homeostasis (GO:2000188) | 2.70787833 |
| 144 | exogenous drug catabolic process (GO:0042738) | 2.70403578 |
| 145 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70340687 |
| 146 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.70048050 |
| 147 | negative regulation of protein activation cascade (GO:2000258) | 2.69234935 |
| 148 | positive regulation of interferon-alpha production (GO:0032727) | 2.67183807 |
| 149 | modulation by virus of host process (GO:0019054) | 2.66905023 |
| 150 | virion assembly (GO:0019068) | 2.66365498 |
| 151 | activation of Rac GTPase activity (GO:0032863) | 2.65890940 |
| 152 | macrophage activation (GO:0042116) | 2.64441035 |
| 153 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.63794977 |
| 154 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.63571421 |
| 155 | apoptotic process involved in morphogenesis (GO:0060561) | 2.62346421 |
| 156 | regulation of interferon-alpha production (GO:0032647) | 2.62076189 |
| 157 | activation of MAPKKK activity (GO:0000185) | 2.60630985 |
| 158 | protein localization to endosome (GO:0036010) | 2.59247113 |
| 159 | amino sugar catabolic process (GO:0046348) | 2.57162909 |
| 160 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.56708876 |
| 161 | negative regulation of interleukin-2 production (GO:0032703) | 2.56639281 |
| 162 | pyrimidine nucleoside salvage (GO:0043097) | 2.55923316 |
| 163 | pyrimidine-containing compound salvage (GO:0008655) | 2.55923316 |
| 164 | regulation of chromatin binding (GO:0035561) | 2.53410740 |
| 165 | response to host (GO:0075136) | 2.53052803 |
| 166 | response to host defenses (GO:0052200) | 2.53052803 |
| 167 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53052803 |
| 168 | negative regulation of interleukin-8 production (GO:0032717) | 2.52804301 |
| 169 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52312556 |
| 170 | Golgi transport vesicle coating (GO:0048200) | 2.52154046 |
| 171 | COPI coating of Golgi vesicle (GO:0048205) | 2.52154046 |
| 172 | germinal center formation (GO:0002467) | 2.50707243 |
| 173 | positive regulation of interferon-beta production (GO:0032728) | 2.49838955 |
| 174 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.47585077 |
| 175 | negative regulation of cell size (GO:0045792) | 2.46750144 |
| 176 | peptidyl-arginine N-methylation (GO:0035246) | 2.46398393 |
| 177 | peptidyl-arginine methylation (GO:0018216) | 2.46398393 |
| 178 | purinergic receptor signaling pathway (GO:0035587) | 2.45662717 |
| 179 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.45402205 |
| 180 | glucose 6-phosphate metabolic process (GO:0051156) | 2.44693177 |
| 181 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.43258375 |
| 182 | pentose-phosphate shunt (GO:0006098) | 2.42625170 |
| 183 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.42440923 |
| 184 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.42144982 |
| 185 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.41246167 |
| 186 | ceramide catabolic process (GO:0046514) | 2.41126082 |
| 187 | regulation of viral release from host cell (GO:1902186) | 2.40403490 |
| 188 | UV protection (GO:0009650) | 2.40318215 |
| 189 | viral protein processing (GO:0019082) | 2.40304831 |
| 190 | respiratory burst (GO:0045730) | 2.39208276 |
| 191 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.38320067 |
| 192 | regulation of ARF GTPase activity (GO:0032312) | 2.37962578 |
| 193 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.37788102 |
| 194 | neutrophil mediated immunity (GO:0002446) | 2.37342514 |
| 195 | immunoglobulin mediated immune response (GO:0016064) | 2.35979218 |
| 196 | semaphorin-plexin signaling pathway (GO:0071526) | 2.35954591 |
| 197 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.35145917 |
| 198 | barbed-end actin filament capping (GO:0051016) | 2.35139786 |
| 199 | positive regulation of T cell apoptotic process (GO:0070234) | 2.34373183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.12209529 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.26890576 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.05919398 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.42417132 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.38457950 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.33926695 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.23291848 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.21172879 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85488362 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58754147 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51580047 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.44974526 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.43936054 |
| 14 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.41485361 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.31500475 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.23979075 |
| 17 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.23377522 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18473858 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.17724563 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.17257275 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.15531384 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14423159 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 2.08304655 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06858335 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05527161 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04406310 |
| 27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.01103386 |
| 28 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.96318949 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.94807497 |
| 30 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.94262128 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.92952348 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88977579 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86027166 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84083330 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83914581 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.83586602 |
| 37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.80383404 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.79094479 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.79094479 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74659415 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72721557 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.72089762 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.70668460 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.69997163 |
| 45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68311898 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68173185 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67707987 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.67577891 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.67147231 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.66452394 |
| 51 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.65747159 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.65667548 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65482251 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65150469 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63999095 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63958214 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63135769 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62211732 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61319686 |
| 60 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57228650 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56607225 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52069957 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50919002 |
| 64 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45442648 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43480348 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42762029 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42690716 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42602059 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.40938404 |
| 70 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40350802 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39284573 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38479605 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37799571 |
| 74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36303612 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36183984 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35938733 |
| 77 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35929626 |
| 78 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.35569011 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35229184 |
| 80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34943328 |
| 81 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.34394079 |
| 82 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.34299430 |
| 83 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.33220171 |
| 84 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.32117000 |
| 85 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.31842602 |
| 86 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31826470 |
| 87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31400629 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31288665 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30255938 |
| 90 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.30122260 |
| 91 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.29877403 |
| 92 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.28467701 |
| 93 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.28115028 |
| 94 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.27727860 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27675614 |
| 96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27272764 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26493454 |
| 98 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26040597 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23873093 |
| 100 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.23785330 |
| 101 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23518327 |
| 102 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.22318843 |
| 103 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22122213 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21835720 |
| 105 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21464868 |
| 106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20981808 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.20638565 |
| 108 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19987243 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19519234 |
| 110 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19501836 |
| 111 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18297623 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17259920 |
| 113 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15977113 |
| 114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15961097 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15836402 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15391857 |
| 117 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14939128 |
| 118 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14396969 |
| 119 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14095719 |
| 120 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13374834 |
| 121 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13354522 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11002524 |
| 123 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08768593 |
| 124 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.08639249 |
| 125 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08630231 |
| 126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07897260 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07201987 |
| 128 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06183707 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05895608 |
| 130 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05166501 |
| 131 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05066303 |
| 132 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04803075 |
| 133 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03413382 |
| 134 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.03210981 |
| 135 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03140707 |
| 136 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02917040 |
| 137 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01935373 |
| 138 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01773128 |
| 139 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00597598 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98809158 |
| 141 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98216812 |
| 142 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97611718 |
| 143 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97007002 |
| 144 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96539212 |
| 145 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96227384 |
| 146 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95731068 |
| 147 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93074726 |
| 148 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92799542 |
| 149 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92574358 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90922711 |
| 151 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89759278 |
| 152 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87994374 |
| 153 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86662165 |
| 154 | AR_19668381_ChIP-Seq_PC3_Human | 0.86537760 |
| 155 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84519933 |
| 156 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84134680 |
| 157 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82634660 |
| 158 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.82580859 |
| 159 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81252237 |
| 160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.80748392 |
| 161 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80726820 |
| 162 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.79195133 |
| 163 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78981581 |
| 164 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78506661 |
| 165 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.77924750 |
| 166 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77768797 |
| 167 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76587439 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75725420 |
| 169 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.75111926 |
| 170 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.75013927 |
| 171 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74692379 |
| 172 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.73544298 |
| 173 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73211648 |
| 174 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.72756134 |
| 175 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.72493290 |
| 176 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72049627 |
| 177 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.71345029 |
| 178 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.71072241 |
| 179 | RXR_22108803_ChIP-Seq_LS180_Human | 0.70150105 |
| 180 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.68950382 |
| 181 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68439705 |
| 182 | TCF4_23295773_ChIP-Seq_U87_Human | 0.68250882 |
| 183 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67446390 |
| 184 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.67090136 |
| 185 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.66194793 |
| 186 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.66160743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.41342175 |
| 2 | MP0005360_urolithiasis | 5.16252535 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.74459061 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.68287867 |
| 5 | MP0005365_abnormal_bile_salt | 4.33163918 |
| 6 | MP0005058_abnormal_lysosome_morphology | 4.31346507 |
| 7 | MP0002822_catalepsy | 4.26797321 |
| 8 | MP0003303_peritoneal_inflammation | 3.92129718 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.55524122 |
| 10 | MP0003436_decreased_susceptibility_to | 3.41122027 |
| 11 | MP0008260_abnormal_autophagy | 2.95123174 |
| 12 | MP0003880_abnormal_central_pattern | 2.94010472 |
| 13 | MP0005451_abnormal_body_composition | 2.93856393 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 2.86067358 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.78669678 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.68488286 |
| 17 | MP0003252_abnormal_bile_duct | 2.67078609 |
| 18 | MP0009745_abnormal_behavioral_response | 2.49506305 |
| 19 | MP0005076_abnormal_cell_differentiation | 2.42450975 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.37459185 |
| 21 | MP0009278_abnormal_bone_marrow | 2.36589267 |
| 22 | MP0002254_reproductive_system_inflammat | 2.35103536 |
| 23 | MP0004270_analgesia | 2.34133089 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.21366987 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 2.19338128 |
| 26 | MP0005083_abnormal_biliary_tract | 2.15126815 |
| 27 | MP0003329_amyloid_beta_deposits | 2.10845629 |
| 28 | MP0002064_seizures | 2.09591559 |
| 29 | MP0009840_abnormal_foam_cell | 1.99298837 |
| 30 | MP0005332_abnormal_amino_acid | 1.97237315 |
| 31 | MP0003195_calcinosis | 1.96391831 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.92410312 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 1.91251188 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.87028734 |
| 35 | MP0001968_abnormal_touch/_nociception | 1.82679975 |
| 36 | MP0005025_abnormal_response_to | 1.82178148 |
| 37 | MP0001873_stomach_inflammation | 1.81933661 |
| 38 | MP0002419_abnormal_innate_immunity | 1.79436073 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.76158716 |
| 40 | MP0004947_skin_inflammation | 1.73836238 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.71218318 |
| 42 | MP0001849_ear_inflammation | 1.64580232 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.63903830 |
| 44 | MP0009046_muscle_twitch | 1.63781017 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.63729619 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.62646225 |
| 47 | MP0000604_amyloidosis | 1.62520118 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.62314189 |
| 49 | MP0003724_increased_susceptibility_to | 1.57779579 |
| 50 | MP0002272_abnormal_nervous_system | 1.57042205 |
| 51 | MP0002723_abnormal_immune_serum | 1.56792619 |
| 52 | MP0005387_immune_system_phenotype | 1.54907887 |
| 53 | MP0001790_abnormal_immune_system | 1.54907887 |
| 54 | MP0000678_abnormal_parathyroid_gland | 1.54133840 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.52220370 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.51889474 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.50636574 |
| 58 | MP0002736_abnormal_nociception_after | 1.49163087 |
| 59 | MP0001486_abnormal_startle_reflex | 1.49138449 |
| 60 | MP0005409_darkened_coat_color | 1.49061677 |
| 61 | MP0000858_altered_metastatic_potential | 1.47714634 |
| 62 | MP0005501_abnormal_skin_physiology | 1.47181885 |
| 63 | MP0001800_abnormal_humoral_immune | 1.46483215 |
| 64 | MP0006082_CNS_inflammation | 1.43232635 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.40833950 |
| 66 | MP0003868_abnormal_feces_composition | 1.37574201 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37014990 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.36865117 |
| 69 | MP0001819_abnormal_immune_cell | 1.36860551 |
| 70 | MP0001835_abnormal_antigen_presentation | 1.35955859 |
| 71 | MP0002420_abnormal_adaptive_immunity | 1.35937120 |
| 72 | MP0003075_altered_response_to | 1.33895026 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.32228356 |
| 74 | MP0008874_decreased_physiological_sensi | 1.29681972 |
| 75 | MP0005535_abnormal_body_temperature | 1.28911244 |
| 76 | MP0002249_abnormal_larynx_morphology | 1.28452941 |
| 77 | MP0001986_abnormal_taste_sensitivity | 1.28276667 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.26609398 |
| 79 | MP0005423_abnormal_somatic_nervous | 1.26494060 |
| 80 | MP0005310_abnormal_salivary_gland | 1.25901829 |
| 81 | MP0003879_abnormal_hair_cell | 1.25356156 |
| 82 | MP0000609_abnormal_liver_physiology | 1.25118465 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 1.24864289 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.24301340 |
| 85 | MP0009785_altered_susceptibility_to | 1.24094091 |
| 86 | MP0002735_abnormal_chemical_nociception | 1.23858434 |
| 87 | MP0000015_abnormal_ear_pigmentation | 1.22518030 |
| 88 | MP0002734_abnormal_mechanical_nocicepti | 1.22466568 |
| 89 | MP0009780_abnormal_chondrocyte_physiolo | 1.22001496 |
| 90 | MP0002796_impaired_skin_barrier | 1.21783338 |
| 91 | MP0010155_abnormal_intestine_physiology | 1.20421425 |
| 92 | MP0003633_abnormal_nervous_system | 1.20220055 |
| 93 | MP0002733_abnormal_thermal_nociception | 1.19283464 |
| 94 | MP0000685_abnormal_immune_system | 1.18690144 |
| 95 | MP0008872_abnormal_physiological_respon | 1.18589478 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 1.14542108 |
| 97 | MP0010234_abnormal_vibrissa_follicle | 1.13909186 |
| 98 | MP0001845_abnormal_inflammatory_respons | 1.13803341 |
| 99 | MP0004381_abnormal_hair_follicle | 1.13239935 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 1.12308186 |
| 101 | MP0001984_abnormal_olfaction | 1.11837908 |
| 102 | MP0002405_respiratory_system_inflammati | 1.08922144 |
| 103 | MP0003300_gastrointestinal_ulcer | 1.08900176 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 1.08523114 |
| 105 | MP0004924_abnormal_behavior | 1.07673740 |
| 106 | MP0005386_behavior/neurological_phenoty | 1.07673740 |
| 107 | MP0002876_abnormal_thyroid_physiology | 1.07580965 |
| 108 | MP0003123_paternal_imprinting | 1.07430368 |
| 109 | MP0003183_abnormal_peptide_metabolism | 1.07293007 |
| 110 | MP0008469_abnormal_protein_level | 1.06061762 |
| 111 | MP0003690_abnormal_glial_cell | 1.05833069 |
| 112 | MP0000716_abnormal_immune_system | 1.04622796 |
| 113 | MP0001970_abnormal_pain_threshold | 1.03495193 |
| 114 | MP0005257_abnormal_intraocular_pressure | 0.97961680 |
| 115 | MP0002067_abnormal_sensory_capabilities | 0.97733258 |
| 116 | MP0002429_abnormal_blood_cell | 0.97199158 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.97031590 |
| 118 | MP0009931_abnormal_skin_appearance | 0.96434190 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.96322782 |
| 120 | MP0001529_abnormal_vocalization | 0.95298609 |
| 121 | MP0001764_abnormal_homeostasis | 0.94924231 |
| 122 | MP0003448_altered_tumor_morphology | 0.94352761 |
| 123 | MP0002398_abnormal_bone_marrow | 0.94293507 |
| 124 | MP0009764_decreased_sensitivity_to | 0.93693354 |
| 125 | MP0004811_abnormal_neuron_physiology | 0.92019833 |
| 126 | MP0008569_lethality_at_weaning | 0.91830980 |
| 127 | MP0000538_abnormal_urinary_bladder | 0.91620315 |
| 128 | MP0001727_abnormal_embryo_implantation | 0.91322802 |
| 129 | MP0003631_nervous_system_phenotype | 0.89937726 |
| 130 | MP0000003_abnormal_adipose_tissue | 0.89469448 |
| 131 | MP0004185_abnormal_adipocyte_glucose | 0.89400538 |
| 132 | MP0000490_abnormal_crypts_of | 0.89170732 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88892549 |
| 134 | MP0004233_abnormal_muscle_weight | 0.87178961 |
| 135 | MP0004130_abnormal_muscle_cell | 0.85975701 |
| 136 | MP0005671_abnormal_response_to | 0.85539218 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.85204165 |
| 138 | MP0001545_abnormal_hematopoietic_system | 0.85204165 |
| 139 | MP0002078_abnormal_glucose_homeostasis | 0.84499981 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.83729969 |
| 141 | MP0002098_abnormal_vibrissa_morphology | 0.83680473 |
| 142 | MP0002066_abnormal_motor_capabilities/c | 0.83509321 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.83154026 |
| 144 | MP0001502_abnormal_circadian_rhythm | 0.82822569 |
| 145 | MP0005375_adipose_tissue_phenotype | 0.82390540 |
| 146 | MP0001188_hyperpigmentation | 0.82155808 |
| 147 | MP0003091_abnormal_cell_migration | 0.82067726 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.81912792 |
| 149 | MP0000343_altered_response_to | 0.81323011 |
| 150 | MP0002653_abnormal_ependyma_morphology | 0.81099330 |
| 151 | MP0002332_abnormal_exercise_endurance | 0.80429259 |
| 152 | MP0008961_abnormal_basal_metabolism | 0.78950366 |
| 153 | MP0000689_abnormal_spleen_morphology | 0.77747786 |
| 154 | MP0005174_abnormal_tail_pigmentation | 0.77649245 |
| 155 | MP0002722_abnormal_immune_system | 0.76698641 |
| 156 | MP0005166_decreased_susceptibility_to | 0.75973452 |
| 157 | MP0005448_abnormal_energy_balance | 0.75930373 |
| 158 | MP0004858_abnormal_nervous_system | 0.75368532 |
| 159 | MP0001216_abnormal_epidermal_layer | 0.74346458 |
| 160 | MP0005167_abnormal_blood-brain_barrier | 0.73007526 |
| 161 | MP0005464_abnormal_platelet_physiology | 0.72824369 |
| 162 | MP0005390_skeleton_phenotype | 0.72168859 |
| 163 | MP0002089_abnormal_postnatal_growth/wei | 0.72094723 |
| 164 | MP0001905_abnormal_dopamine_level | 0.71733586 |
| 165 | MP0002184_abnormal_innervation | 0.71554070 |
| 166 | MP0006276_abnormal_autonomic_nervous | 0.71472869 |
| 167 | MP0001765_abnormal_ion_homeostasis | 0.70384519 |
| 168 | MP0005636_abnormal_mineral_homeostasis | 0.70240847 |
| 169 | MP0002090_abnormal_vision | 0.69555364 |
| 170 | MP0004142_abnormal_muscle_tone | 0.67724117 |
| 171 | MP0000955_abnormal_spinal_cord | 0.66410641 |
| 172 | MP0009642_abnormal_blood_homeostasis | 0.64985925 |
| 173 | MP0009643_abnormal_urine_homeostasis | 0.63624160 |
| 174 | MP0004885_abnormal_endolymph | 0.63358222 |
| 175 | MP0003656_abnormal_erythrocyte_physiolo | 0.62616087 |
| 176 | MP0004510_myositis | 0.61169547 |
| 177 | MP0000639_abnormal_adrenal_gland | 0.61094370 |
| 178 | MP0003953_abnormal_hormone_level | 0.60702767 |
| 179 | MP0000013_abnormal_adipose_tissue | 0.60163002 |
| 180 | MP0005334_abnormal_fat_pad | 0.57315900 |
| 181 | MP0006035_abnormal_mitochondrial_morpho | 0.55510216 |
| 182 | MP0003638_abnormal_response/metabolism_ | 0.54174982 |
| 183 | MP0002882_abnormal_neuron_morphology | 0.53610787 |
| 184 | MP0002229_neurodegeneration | 0.53608206 |
| 185 | MP0005187_abnormal_penis_morphology | 0.53377925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.80138272 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.57265943 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.84749651 |
| 4 | Myokymia (HP:0002411) | 4.82540057 |
| 5 | Focal motor seizures (HP:0011153) | 4.76551275 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.70088355 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.68763466 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.58225343 |
| 9 | Xanthomatosis (HP:0000991) | 4.55143459 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.27148190 |
| 11 | Complement deficiency (HP:0004431) | 3.96588638 |
| 12 | Thin bony cortex (HP:0002753) | 3.80209263 |
| 13 | Ketosis (HP:0001946) | 3.69736526 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.65494682 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.65494682 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.65494682 |
| 17 | Hyperventilation (HP:0002883) | 3.57458066 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.56094509 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.47757575 |
| 20 | Testicular atrophy (HP:0000029) | 3.46989069 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.45535822 |
| 22 | Focal seizures (HP:0007359) | 3.43950783 |
| 23 | Loss of speech (HP:0002371) | 3.32256482 |
| 24 | Hyperglycinemia (HP:0002154) | 3.31368336 |
| 25 | Hyperammonemia (HP:0001987) | 3.30361846 |
| 26 | Epidermoid cyst (HP:0200040) | 3.29806713 |
| 27 | Hypolipoproteinemia (HP:0010981) | 3.28446467 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22999892 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.22999892 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22999892 |
| 31 | Joint hemorrhage (HP:0005261) | 3.22069889 |
| 32 | Visual hallucinations (HP:0002367) | 3.21646549 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.20884217 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.20406401 |
| 35 | Status epilepticus (HP:0002133) | 3.13873494 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.10953176 |
| 37 | Hemorrhage of the eye (HP:0011885) | 3.10173787 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.08829892 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.99913478 |
| 40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99287296 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.99287296 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.96338176 |
| 43 | Ulnar bowing (HP:0003031) | 2.94302418 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.92481637 |
| 45 | Fat malabsorption (HP:0002630) | 2.89511757 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.88101342 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87731557 |
| 48 | Spontaneous abortion (HP:0005268) | 2.81015592 |
| 49 | Ketoacidosis (HP:0001993) | 2.80575164 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.79986591 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.79826441 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.79068063 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.78822170 |
| 54 | Torticollis (HP:0000473) | 2.76755471 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76439411 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.76439411 |
| 57 | Focal dystonia (HP:0004373) | 2.74599913 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.73329755 |
| 59 | Hypoalphalipoproteinemia (HP:0003233) | 2.73059747 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.71678678 |
| 61 | Akinesia (HP:0002304) | 2.70224567 |
| 62 | Abnormal social behavior (HP:0012433) | 2.67422204 |
| 63 | Impaired social interactions (HP:0000735) | 2.67422204 |
| 64 | Abnormality of complement system (HP:0005339) | 2.65227384 |
| 65 | Craniofacial dystonia (HP:0012179) | 2.64660767 |
| 66 | Poor eye contact (HP:0000817) | 2.63763362 |
| 67 | Cellulitis (HP:0100658) | 2.63369845 |
| 68 | Hypercholesterolemia (HP:0003124) | 2.62119059 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 2.61545438 |
| 70 | Gout (HP:0001997) | 2.61521201 |
| 71 | Generalized tonic-clonic seizures (HP:0002069) | 2.61406112 |
| 72 | Hyperglycinuria (HP:0003108) | 2.59325830 |
| 73 | Abnormality of the lower motor neuron (HP:0002366) | 2.59233882 |
| 74 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54234279 |
| 75 | Obstructive lung disease (HP:0006536) | 2.54120310 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54120310 |
| 77 | Epileptic encephalopathy (HP:0200134) | 2.53363082 |
| 78 | Conjugated hyperbilirubinemia (HP:0002908) | 2.52175373 |
| 79 | J-shaped sella turcica (HP:0002680) | 2.51665784 |
| 80 | Long palpebral fissure (HP:0000637) | 2.49857911 |
| 81 | Cholecystitis (HP:0001082) | 2.48514228 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.48514228 |
| 83 | Absence seizures (HP:0002121) | 2.46840156 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46694142 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.45460133 |
| 86 | Anxiety (HP:0000739) | 2.44641326 |
| 87 | Hypertensive crisis (HP:0100735) | 2.42749698 |
| 88 | Vaginal fistula (HP:0004320) | 2.41007088 |
| 89 | Rapidly progressive (HP:0003678) | 2.39955243 |
| 90 | Annular pancreas (HP:0001734) | 2.39319954 |
| 91 | Upper limb amyotrophy (HP:0009129) | 2.38756777 |
| 92 | Distal upper limb amyotrophy (HP:0007149) | 2.38756777 |
| 93 | Neonatal onset (HP:0003623) | 2.38416453 |
| 94 | Interstitial pulmonary disease (HP:0006530) | 2.36326359 |
| 95 | Sensorimotor neuropathy (HP:0007141) | 2.36291812 |
| 96 | Progressive neurologic deterioration (HP:0002344) | 2.34578918 |
| 97 | Postural instability (HP:0002172) | 2.34139027 |
| 98 | Hyperacusis (HP:0010780) | 2.34004276 |
| 99 | Hypoglycemic coma (HP:0001325) | 2.32421305 |
| 100 | Hyperbilirubinemia (HP:0002904) | 2.32179440 |
| 101 | Skin nodule (HP:0200036) | 2.31338971 |
| 102 | Amyloidosis (HP:0011034) | 2.29816168 |
| 103 | Peripheral hypomyelination (HP:0007182) | 2.29258435 |
| 104 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.28465222 |
| 105 | Dialeptic seizures (HP:0011146) | 2.28174821 |
| 106 | Bulbar palsy (HP:0001283) | 2.27660438 |
| 107 | Increased serum ferritin (HP:0003281) | 2.24435465 |
| 108 | Action tremor (HP:0002345) | 2.20310824 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 2.19960999 |
| 110 | Turricephaly (HP:0000262) | 2.18188571 |
| 111 | Atonic seizures (HP:0010819) | 2.17499329 |
| 112 | Dysmetria (HP:0001310) | 2.17154876 |
| 113 | Dysdiadochokinesis (HP:0002075) | 2.14972726 |
| 114 | Micronodular cirrhosis (HP:0001413) | 2.14115587 |
| 115 | Truncus arteriosus (HP:0001660) | 2.14023777 |
| 116 | Ankle clonus (HP:0011448) | 2.13922301 |
| 117 | Steatorrhea (HP:0002570) | 2.13913886 |
| 118 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13038657 |
| 119 | Progressive cerebellar ataxia (HP:0002073) | 2.12873090 |
| 120 | Supranuclear gaze palsy (HP:0000605) | 2.12794295 |
| 121 | Epileptiform EEG discharges (HP:0011182) | 2.11841910 |
| 122 | Prolonged neonatal jaundice (HP:0006579) | 2.11512497 |
| 123 | Scanning speech (HP:0002168) | 2.10867178 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10581194 |
| 125 | Metabolic acidosis (HP:0001942) | 2.10261188 |
| 126 | Impaired vibratory sensation (HP:0002495) | 2.10222867 |
| 127 | Diminished motivation (HP:0000745) | 2.09918573 |
| 128 | Poikiloderma (HP:0001029) | 2.09161646 |
| 129 | Dementia (HP:0000726) | 2.08623449 |
| 130 | Hand muscle atrophy (HP:0009130) | 2.06879688 |
| 131 | Depression (HP:0000716) | 2.06253523 |
| 132 | Mitral stenosis (HP:0001718) | 2.06144018 |
| 133 | Stridor (HP:0010307) | 2.04701266 |
| 134 | Irritability (HP:0000737) | 2.02713139 |
| 135 | Hypochromic microcytic anemia (HP:0004840) | 2.02478574 |
| 136 | Broad distal phalanx of finger (HP:0009836) | 2.02134140 |
| 137 | Global brain atrophy (HP:0002283) | 2.01524246 |
| 138 | Abnormality of serum amino acid levels (HP:0003112) | 2.01345416 |
| 139 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00448271 |
| 140 | Joint stiffness (HP:0001387) | 1.99876696 |
| 141 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.99211541 |
| 142 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.98313892 |
| 143 | Dysmetric saccades (HP:0000641) | 1.98203095 |
| 144 | Abnormality of the Achilles tendon (HP:0005109) | 1.98084121 |
| 145 | Febrile seizures (HP:0002373) | 1.97725398 |
| 146 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97706760 |
| 147 | Abnormality of purine metabolism (HP:0004352) | 1.97403194 |
| 148 | Abnormal gallbladder morphology (HP:0012437) | 1.97322521 |
| 149 | Myositis (HP:0100614) | 1.96479499 |
| 150 | Axonal loss (HP:0003447) | 1.96428626 |
| 151 | Hypsarrhythmia (HP:0002521) | 1.95508679 |
| 152 | Cholelithiasis (HP:0001081) | 1.94746790 |
| 153 | Mesangial abnormality (HP:0001966) | 1.94380211 |
| 154 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.94379574 |
| 155 | Acanthocytosis (HP:0001927) | 1.93926993 |
| 156 | Fair hair (HP:0002286) | 1.93521763 |
| 157 | Apathy (HP:0000741) | 1.92429163 |
| 158 | Abnormality of the thoracic spine (HP:0100711) | 1.92069323 |
| 159 | Abnormal trabecular bone morphology (HP:0100671) | 1.91323201 |
| 160 | Tetraplegia (HP:0002445) | 1.90402964 |
| 161 | Myopathic facies (HP:0002058) | 1.90016988 |
| 162 | Achilles tendon contracture (HP:0001771) | 1.89856533 |
| 163 | Generalized myoclonic seizures (HP:0002123) | 1.89361864 |
| 164 | Intestinal fistula (HP:0100819) | 1.89079156 |
| 165 | Distal lower limb amyotrophy (HP:0008944) | 1.88493451 |
| 166 | Nuclear cataract (HP:0100018) | 1.88212765 |
| 167 | Upper motor neuron abnormality (HP:0002127) | 1.87041168 |
| 168 | Confusion (HP:0001289) | 1.86928296 |
| 169 | Colitis (HP:0002583) | 1.85397001 |
| 170 | Orchitis (HP:0100796) | 1.84656200 |
| 171 | Malnutrition (HP:0004395) | 1.81957082 |
| 172 | Vertebral compression fractures (HP:0002953) | 1.79942728 |
| 173 | Delayed epiphyseal ossification (HP:0002663) | 1.78594528 |
| 174 | Easy fatigability (HP:0003388) | 1.78444922 |
| 175 | Gastrointestinal dysmotility (HP:0002579) | 1.76804127 |
| 176 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.76694876 |
| 177 | Diminished movement (HP:0002374) | 1.73773164 |
| 178 | Urinary incontinence (HP:0000020) | 1.73277374 |
| 179 | Rectal fistula (HP:0100590) | 1.73224594 |
| 180 | Rectovaginal fistula (HP:0000143) | 1.73224594 |
| 181 | Recurrent skin infections (HP:0001581) | 1.72594659 |
| 182 | Rough bone trabeculation (HP:0100670) | 1.71680876 |
| 183 | Abnormality of the gallbladder (HP:0005264) | 1.69747926 |
| 184 | Bone pain (HP:0002653) | 1.69495022 |
| 185 | Nonimmune hydrops fetalis (HP:0001790) | 1.68465790 |
| 186 | Gingivitis (HP:0000230) | 1.68238087 |
| 187 | Emphysema (HP:0002097) | 1.67760639 |
| 188 | Genu recurvatum (HP:0002816) | 1.67392571 |
| 189 | Meningitis (HP:0001287) | 1.66754037 |
| 190 | Systemic lupus erythematosus (HP:0002725) | 1.65673416 |
| 191 | Flattened epiphyses (HP:0003071) | 1.65015452 |
| 192 | Facial hemangioma (HP:0000329) | 1.64219104 |
| 193 | Reticulocytosis (HP:0001923) | 1.64016500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.93063845 |
| 2 | NTRK3 | 3.93391128 |
| 3 | MAP3K9 | 3.41139091 |
| 4 | IRAK3 | 3.37855802 |
| 5 | DAPK2 | 3.26381431 |
| 6 | MAP3K11 | 3.03206132 |
| 7 | RIPK4 | 2.82473453 |
| 8 | SMG1 | 2.63285258 |
| 9 | NME2 | 2.62865224 |
| 10 | KSR2 | 2.44577701 |
| 11 | MAP2K4 | 2.43340775 |
| 12 | TESK2 | 2.35007666 |
| 13 | MAP3K4 | 2.29895677 |
| 14 | ICK | 2.28999576 |
| 15 | MAP3K13 | 2.05192710 |
| 16 | DAPK1 | 2.04688750 |
| 17 | MINK1 | 2.04182817 |
| 18 | EPHA2 | 1.97072575 |
| 19 | MAP2K7 | 1.95350222 |
| 20 | IRAK4 | 1.91704863 |
| 21 | SIK3 | 1.88301615 |
| 22 | BCKDK | 1.87907305 |
| 23 | CAMKK1 | 1.84689929 |
| 24 | MAP3K12 | 1.83410899 |
| 25 | PRKD3 | 1.80111451 |
| 26 | MAP2K3 | 1.77761071 |
| 27 | TBK1 | 1.77262339 |
| 28 | BLK | 1.75072422 |
| 29 | ARAF | 1.69807636 |
| 30 | MAP4K1 | 1.66734437 |
| 31 | NTRK1 | 1.63714703 |
| 32 | TESK1 | 1.63424319 |
| 33 | KSR1 | 1.57927102 |
| 34 | PAK6 | 1.55972421 |
| 35 | IRAK2 | 1.54191459 |
| 36 | MAP3K3 | 1.49497308 |
| 37 | MARK1 | 1.48960755 |
| 38 | EPHB1 | 1.46505765 |
| 39 | NTRK2 | 1.46138555 |
| 40 | FES | 1.44595674 |
| 41 | PIM2 | 1.41615964 |
| 42 | SIK2 | 1.38528717 |
| 43 | MAPK15 | 1.30665842 |
| 44 | ERN1 | 1.28513685 |
| 45 | RAF1 | 1.27390284 |
| 46 | CDK5 | 1.26823714 |
| 47 | PRKCG | 1.25071171 |
| 48 | RIPK1 | 1.22581905 |
| 49 | TAOK1 | 1.22410278 |
| 50 | DYRK1B | 1.20912944 |
| 51 | MAP3K2 | 1.16848313 |
| 52 | IKBKE | 1.16518518 |
| 53 | EEF2K | 1.14282665 |
| 54 | MAP3K7 | 1.11757338 |
| 55 | MAP2K2 | 1.09809238 |
| 56 | MATK | 1.05223349 |
| 57 | FGFR4 | 1.03095759 |
| 58 | PTK2B | 1.02867268 |
| 59 | STK38 | 1.01915502 |
| 60 | ZAP70 | 1.01002560 |
| 61 | PINK1 | 1.00002648 |
| 62 | MAP3K1 | 0.98455153 |
| 63 | RPS6KA2 | 0.98144556 |
| 64 | BMPR2 | 0.96006207 |
| 65 | CAMKK2 | 0.95675655 |
| 66 | PRKCH | 0.94219928 |
| 67 | GRK5 | 0.93881611 |
| 68 | GRK6 | 0.93372807 |
| 69 | INSRR | 0.92793069 |
| 70 | PDK1 | 0.92098336 |
| 71 | PDPK1 | 0.90937911 |
| 72 | CAMK1 | 0.90510646 |
| 73 | SGK3 | 0.89886714 |
| 74 | SGK2 | 0.87957791 |
| 75 | MARK2 | 0.87033655 |
| 76 | CAMK2A | 0.86977092 |
| 77 | SIK1 | 0.86801250 |
| 78 | PTK6 | 0.85569135 |
| 79 | PAK4 | 0.84441906 |
| 80 | RET | 0.84374424 |
| 81 | SGK494 | 0.83562187 |
| 82 | SGK223 | 0.83562187 |
| 83 | IKBKB | 0.82571452 |
| 84 | PRKCZ | 0.80968427 |
| 85 | PKN2 | 0.79390245 |
| 86 | PLK2 | 0.79326774 |
| 87 | TAOK3 | 0.78417608 |
| 88 | CAMK2B | 0.77321300 |
| 89 | RPS6KL1 | 0.76604350 |
| 90 | RPS6KC1 | 0.76604350 |
| 91 | CHUK | 0.75858263 |
| 92 | MAP3K14 | 0.75200771 |
| 93 | TRIB3 | 0.72599588 |
| 94 | TNIK | 0.70917454 |
| 95 | TYRO3 | 0.69872222 |
| 96 | CSK | 0.69727242 |
| 97 | STK11 | 0.67706648 |
| 98 | PRPF4B | 0.65164729 |
| 99 | SGK1 | 0.64732882 |
| 100 | MUSK | 0.62630639 |
| 101 | CDK19 | 0.62402488 |
| 102 | RPS6KA6 | 0.62207474 |
| 103 | MAP2K1 | 0.62015080 |
| 104 | TYK2 | 0.61615309 |
| 105 | CDC42BPA | 0.60052303 |
| 106 | CAMK2G | 0.59846068 |
| 107 | MAP3K5 | 0.59299418 |
| 108 | DAPK3 | 0.59159485 |
| 109 | MAPK12 | 0.59087992 |
| 110 | TNK2 | 0.57743696 |
| 111 | MAP2K6 | 0.57236911 |
| 112 | BMX | 0.55462068 |
| 113 | KDR | 0.54909053 |
| 114 | CASK | 0.54754669 |
| 115 | CAMK4 | 0.54534898 |
| 116 | CDK12 | 0.54237692 |
| 117 | PRKCQ | 0.53611714 |
| 118 | PAK3 | 0.53540618 |
| 119 | HIPK2 | 0.53039920 |
| 120 | CDK18 | 0.51072465 |
| 121 | CDK15 | 0.51022617 |
| 122 | CSNK1G2 | 0.50512291 |
| 123 | PNCK | 0.50245162 |
| 124 | MTOR | 0.49897203 |
| 125 | MAP3K8 | 0.49696030 |
| 126 | PRKG2 | 0.48430832 |
| 127 | MAPK11 | 0.47664495 |
| 128 | PRKCI | 0.47522954 |
| 129 | DDR2 | 0.46468121 |
| 130 | CAMK1G | 0.46255126 |
| 131 | RPS6KA3 | 0.44825668 |
| 132 | FYN | 0.44550105 |
| 133 | JAK2 | 0.43656771 |
| 134 | MAPKAPK2 | 0.43536233 |
| 135 | CDK14 | 0.43338403 |
| 136 | DYRK1A | 0.42917399 |
| 137 | BTK | 0.42582249 |
| 138 | ABL2 | 0.42252590 |
| 139 | TLK1 | 0.41928464 |
| 140 | PRKACG | 0.41582061 |
| 141 | CDK11A | 0.40535675 |
| 142 | MAP3K6 | 0.39690755 |
| 143 | DYRK3 | 0.39341740 |
| 144 | JAK3 | 0.39236139 |
| 145 | ERBB4 | 0.38867956 |
| 146 | AURKA | 0.38812444 |
| 147 | LMTK2 | 0.38048244 |
| 148 | BRAF | 0.36703923 |
| 149 | RPS6KA1 | 0.36677706 |
| 150 | CDK4 | 0.36546937 |
| 151 | IRAK1 | 0.36455484 |
| 152 | TAOK2 | 0.36199217 |
| 153 | PRKD2 | 0.36145836 |
| 154 | SYK | 0.35832239 |
| 155 | HCK | 0.35827581 |
| 156 | MAPK4 | 0.35177926 |
| 157 | PRKCA | 0.34910593 |
| 158 | MAP3K10 | 0.34692288 |
| 159 | FGFR2 | 0.34579755 |
| 160 | FGR | 0.33449724 |
| 161 | MAPK13 | 0.33438311 |
| 162 | PRKCB | 0.32184447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.11744406 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94925476 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.67712101 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.50298748 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83510740 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.62183093 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39765771 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.37923666 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.19866684 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09534016 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.05246047 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97221862 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97124394 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.94822676 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94546481 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91706755 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.90570680 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88534504 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86677118 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.85977106 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.79181054 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.78417683 |
| 23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.71010110 |
| 24 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.69990445 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.69545608 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68880645 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68627277 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.68041188 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65853984 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56015994 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55635461 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.55364359 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.53410706 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51583903 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.49368780 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49207157 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47500935 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46372955 |
| 39 | GABAergic synapse_Homo sapiens_hsa04727 | 1.46190000 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45652733 |
| 41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.43749597 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39853748 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.39456592 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38626413 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38117798 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.37027626 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.34427662 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33712912 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.33148860 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.32728526 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32438828 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31424735 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29452032 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27277387 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.25857692 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23916539 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.23288972 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 1.22842548 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 1.22640176 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21693103 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.21506116 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21178214 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18603585 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.18301319 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18110877 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16905938 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16656033 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16100635 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13669278 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 1.13367279 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11778062 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11680127 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 1.11480942 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 1.11257433 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 1.10546900 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09648479 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08659522 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07688453 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05103964 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03957478 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.03238813 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02638219 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 1.02117586 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.01658897 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01633106 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 1.01353841 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01185426 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98431256 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96714934 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95849796 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94958836 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93877511 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.93360165 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.92734256 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.89008279 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87535870 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.86881058 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86854454 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86522033 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.86463274 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83868808 |
| 102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83090238 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83058695 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82715450 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82360251 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.81807398 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81143502 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80847720 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80611440 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80247895 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78774962 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78658884 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78046628 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77702264 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77526161 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76999246 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76855212 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75636905 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73832028 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73492104 |
| 121 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73488687 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73447224 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.73132393 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73002906 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71684054 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70728630 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.69574896 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68285873 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67127787 |
| 130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67080610 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67067606 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65678739 |
| 133 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65605917 |
| 134 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64138701 |
| 135 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64114956 |
| 136 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63379531 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62229106 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61766570 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.60836722 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60257179 |
| 141 | Long-term depression_Homo sapiens_hsa04730 | 0.59588266 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59321709 |
| 143 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59247602 |
| 144 | Base excision repair_Homo sapiens_hsa03410 | 0.59132032 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57525890 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56770542 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56202055 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56042013 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.55830145 |
| 150 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55710830 |
| 151 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54470695 |
| 152 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54283208 |
| 153 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54026007 |
| 154 | Measles_Homo sapiens_hsa05162 | 0.53345145 |
| 155 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52719317 |
| 156 | Allograft rejection_Homo sapiens_hsa05330 | 0.50119895 |
| 157 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50105713 |
| 158 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49976768 |
| 159 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48328487 |
| 160 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47936060 |
| 161 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47497625 |
| 162 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46136539 |
| 163 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45855193 |
| 164 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45816957 |
| 165 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45535612 |
| 166 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45386007 |
| 167 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44505664 |
| 168 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44267830 |
| 169 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44042784 |
| 170 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43963046 |
| 171 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43872059 |
| 172 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43321676 |
| 173 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42620323 |
| 174 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41821641 |
| 175 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39309252 |
| 176 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39298990 |
| 177 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39241727 |
| 178 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38782426 |
| 179 | Gap junction_Homo sapiens_hsa04540 | 0.37438829 |
| 180 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35543366 |
| 181 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34900144 |
| 182 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33669593 |
| 183 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33180635 |
| 184 | Glioma_Homo sapiens_hsa05214 | 0.33155987 |
| 185 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32806766 |

